Serophene: Clinically Proven Ovulation Induction Therapy
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.51 | $75.30 (0%) | 🛒 Add to cart |
| 60 | $1.96 | $150.61 $117.48 (22%) | 🛒 Add to cart |
| 90 | $1.77 | $225.91 $159.65 (29%) | 🛒 Add to cart |
| 120 | $1.68 | $301.22 $201.82 (33%) | 🛒 Add to cart |
| 180 | $1.59 | $451.83 $286.16 (37%) | 🛒 Add to cart |
| 270 | $1.53 | $677.74 $412.67 (39%) | 🛒 Add to cart |
| 360 | $1.50
Best per pill | $903.66 $539.18 (40%) | 🛒 Add to cart |
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.54 | $48.20 (0%) | 🛒 Add to cart |
| 120 | $0.50 | $64.26 $60.24 (6%) | 🛒 Add to cart |
| 180 | $0.47 | $96.39 $84.34 (12%) | 🛒 Add to cart |
| 270 | $0.45 | $144.59 $120.49 (17%) | 🛒 Add to cart |
| 360 | $0.44
Best per pill | $192.78 $156.63 (19%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.34 | $40.16 (0%) | 🛒 Add to cart |
| 60 | $1.04 | $80.33 $62.25 (23%) | 🛒 Add to cart |
| 90 | $0.94 | $120.49 $84.34 (30%) | 🛒 Add to cart |
| 120 | $0.90 | $160.65 $107.43 (33%) | 🛒 Add to cart |
| 180 | $0.85 | $240.98 $152.62 (37%) | 🛒 Add to cart |
| 270 | $0.81 | $361.46 $219.89 (39%) | 🛒 Add to cart |
| 360 | $0.80
Best per pill | $481.95 $287.16 (40%) | 🛒 Add to cart |
Synonyms | |||
Serophene (clomiphene citrate) is a first-line oral fertility medication specifically designed to stimulate ovulation in women experiencing anovulatory infertility. As a selective estrogen receptor modulator (SERM), it works by blocking estrogen receptors in the hypothalamus, prompting increased secretion of gonadotropin-releasing hormone (GnRH). This cascade stimulates the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH), ultimately promoting follicular development and maturation. Its established efficacy, favorable safety profile, and oral administration make it a cornerstone of fertility treatment protocols worldwide. This medication is typically prescribed after a thorough diagnostic workup to identify appropriate candidates.
Features
- Active ingredient: Clomiphene citrate
- Standard dosage forms: 50 mg tablets
- Administration: Oral
- Mechanism of action: Selective estrogen receptor modulator (SERM)
- Bioavailability: Highly variable between individuals
- Half-life: Approximately 5-7 days
- Excretion: Primarily fecal, with some urinary elimination
- Pregnancy category: Formerly Category X (not for use during pregnancy)
Benefits
- Effectively induces ovulation in approximately 80% of appropriately selected anovulatory women
- Non-invasive oral administration compared to injectable fertility medications
- Lower cost alternative to many other fertility treatments
- Well-established safety profile with decades of clinical use
- Enables timed intercourse or intrauterine insemination (IUI) cycles
- May help normalize menstrual cycles in women with oligo-ovulation
Common use
Serophene is primarily indicated for the treatment of ovulatory dysfunction in women desiring pregnancy. The most common patient population includes women with polycystic ovary syndrome (PCOS) who are not ovulating regularly. It may also be prescribed for women with unexplained infertility as part of controlled ovarian stimulation protocols. Treatment is typically initiated only after other causes of infertility have been evaluated and addressed, including assessment of tubal patency, uterine abnormalities, and male factor infertility. Many reproductive endocrinologists recommend pretreatment with oral contraceptives to synchronize follicular development in women with irregular cycles.
Dosage and direction
The initial recommended dosage is 50 mg (one tablet) daily for five days, beginning on the third, fourth, or fifth day of the menstrual cycle. Treatment may be started at any time in women with amenorrhea following a progestin-induced withdrawal bleed. The five-day course is typically repeated for up to three cycles, with ovulation usually occurring 5-10 days after the last dose. If ovulation does not occur at the 50 mg dose, the dosage may be increased to 100 mg daily for five days in subsequent cycles. The maximum recommended daily dose is 100 mg, though some specialists may cautiously prescribe 150 mg in resistant cases. Dosage adjustments should only be made under strict medical supervision with appropriate monitoring.
Precautions
Patients should undergo thorough gynecologic and endocrine evaluation before beginning treatment. Baseline assessment should include documentation of anovulation, evaluation of hepatic function, and assessment of thyroid and adrenal function. Pelvic examination is necessary to rule out ovarian enlargement or cysts. Visual symptoms should be promptly reported, as these may indicate serious adverse effects. Multiple pregnancy occurs in approximately 8% of pregnancies, with twins being most common. The incidence of ovarian hyperstimulation syndrome (OHSS) is low but requires vigilance. Long-term use (more than six cycles) may be associated with increased risk of ovarian cancer, though data remains controversial.
Contraindications
Serophene is contraindicated in patients with liver disease or a history of liver dysfunction. It should not be used in women with ovarian cysts not due to polycystic ovarian syndrome or unexplained abnormal genital bleeding. Patients with uncontrolled thyroid or adrenal dysfunction, organic intracranial lesions such as pituitary tumors, or those who are pregnant should not take this medication. It is contraindicated in women with known hypersensitivity to clomiphene citrate or any component of the formulation. The medication is not indicated for use in men.
Possible side effect
Common side effects include vasomotor flushes (similar to hot flashes) in approximately 10% of patients, abdominal discomfort or bloating (7%), ovarian enlargement (5%), and breast tenderness (2%). Visual disturbances such as blurring, spots, or flashes (phosphenes) occur in approximately 1.5% of patients and usually resolve after discontinuation. Less common effects include nausea, vomiting, nervousness, insomnia, headache, dizziness, lightheadedness, increased urination, heavy menses, and weight gain. Rare but serious adverse effects include ovarian hyperstimulation syndrome, which can be life-threatening in severe cases.
Drug interaction
Serophene may interact with several medications, including anticoagulants (may potentiate effects), thyroxine (may require dosage adjustment), and other hormonal therapies. Concomitant use with gonadotropins may increase the risk of ovarian hyperstimulation. Medications that induce liver enzymes, such as rifampin or certain anticonvulsants, may reduce clomiphene levels and effectiveness. Herbal supplements with estrogenic properties, such as black cohosh or soy isoflavones, may interfere with its mechanism of action. Always inform your healthcare provider of all medications, including over-the-counter drugs and supplements.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one. Contact your healthcare provider for specific instructions, as the timing of medication during the menstrual cycle is critical for optimal effectiveness. Consistency in dosing is important for achieving predictable ovarian response. If multiple doses are missed, your treatment cycle may need to be restarted or adjusted.
Overdose
Symptoms of overdose may include nausea, vomiting, vasomotor flushes, visual disturbances, abdominal pain, and ovarian enlargement with pelvic discomfort. There is no specific antidote for clomiphene citrate overdose. Treatment should be symptomatic and supportive. In cases of recent ingestion, gastric lavage may be considered. Due to the enterohepatic circulation of the drug, multiple-dose activated charcoal may be beneficial. Patients should be monitored for signs of ovarian hyperstimulation syndrome, which may require hospitalization and management of fluid and electrolyte imbalances.
Storage
Store at controlled room temperature between 20°C to 25°C (68°F to 77°F). Excursions are permitted between 15°C to 30°C (59°F to 86°F). Keep the container tightly closed and protect from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Properly discard any unused medication after treatment completion, as it should not be saved for future cycles without medical supervision.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Serophene is a prescription medication that should only be used under the supervision of a qualified healthcare provider. Individual results may vary, and not all patients will respond to treatment. The prescribing physician should thoroughly evaluate each patient’s specific medical situation before initiating therapy. Always follow your healthcare provider’s instructions regarding dosage, monitoring, and follow-up care.
Reviews
Clinical studies demonstrate that approximately 80% of appropriately selected anovulatory women will ovulate in response to clomiphene citrate, with cumulative pregnancy rates of approximately 30-40% after three to six treatment cycles. Many reproductive endocrinologists consider it the first-line treatment for WHO Group II anovulation. Patient satisfaction surveys indicate appreciation for its oral administration and relatively low cost compared to injectable alternatives. However, some patients report frustration with side effects, particularly vasomotor symptoms, and the emotional challenges of timed intercourse. Success rates decline with advancing maternal age and the presence of additional fertility factors.